Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Kevin Mwangi

Faculty of Pharmaceutical Sciences > Department of Pharmaceutics

ORCID iD: 0000-0003-1742-4865

Add to list
- Journal Article
- open access
Development of propylated starch-based nanoparticles for Amphotericin B delivery

Yonas Brhane, Anteneh Belete, Stefaan De Smedt (UGent) , Kevin Mwangi (UGent) , Katrien Remaut (UGent) and Tsige Gebre-Mariam

(2026) International Journal of Pharmaceutics. 687.
Add to list
- Journal Article
- A1
- open access
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

Arne van der Vreken, Fabien Henri Thery (UGent) , Chenggong Tu, Kevin Mwangi (UGent) , Sofie Meulewaeter (UGent) , Lien De Beck, Edith Janssens, Kim De Veirman, Karin Vanderkerken, Elke De Bruyne, et al.

(2025) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 13(4).
Add to list
- Journal Article
- A1
- open access
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Sofie Meulewaeter (UGent) , Margo De Velder (UGent) , Diethard Reckelbus (UGent) , Kevin Mwangi (UGent) , Thomas Ehouarne (UGent) , Ilke Aernout (UGent) , Yanou Engelen (UGent) , Fëllanza Halimi (UGent) , Isis Van herteryck (UGent) , Lobke De Bels (UGent) , et al.

(2025) MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. 33(2).